Luis Miguel Blanco‐Colio

9.8k total citations
193 papers, 7.9k citations indexed

About

Luis Miguel Blanco‐Colio is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Luis Miguel Blanco‐Colio has authored 193 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 61 papers in Surgery and 59 papers in Immunology. Recurrent topics in Luis Miguel Blanco‐Colio's work include Lipoproteins and Cardiovascular Health (31 papers), Aortic aneurysm repair treatments (31 papers) and NF-κB Signaling Pathways (30 papers). Luis Miguel Blanco‐Colio is often cited by papers focused on Lipoproteins and Cardiovascular Health (31 papers), Aortic aneurysm repair treatments (31 papers) and NF-κB Signaling Pathways (30 papers). Luis Miguel Blanco‐Colio collaborates with scholars based in Spain, France and United States. Luis Miguel Blanco‐Colio's co-authors include Jesús Egido, José Luis Martín‐Ventura, Alberto Ortíz, José Tuñón, Juan Antonio Moreno, Julio Madrigal‐Matute, Olivier Meilhac, Begoña Muñoz‐García, Luís Ortega and Mónica Ortego and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Luis Miguel Blanco‐Colio

185 papers receiving 7.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luis Miguel Blanco‐Colio Spain	51	2.9k	2.0k	1.9k	1.6k	1.2k	193	7.9k
José Luis Martín‐Ventura Spain	49	2.6k 0.9×	1.8k 0.9×	1.7k 0.8×	1.3k 0.8×	1.3k 1.0×	189	7.2k
Olivier Meilhac France	51	2.2k 0.8×	1.5k 0.8×	1.7k 0.9×	903 0.6×	898 0.7×	217	8.0k
Magnus Bäck Sweden	49	2.1k 0.7×	2.0k 1.0×	1.6k 0.8×	663 0.4×	2.1k 1.7×	190	8.5k
Karin Bornfeldt United States	53	5.2k 1.8×	2.3k 1.2×	1.8k 0.9×	1.3k 0.8×	1.7k 1.4×	151	11.1k
Diana M. Stafforini United States	44	2.3k 0.8×	1.5k 0.8×	2.0k 1.0×	914 0.6×	784 0.6×	84	7.8k
Mark Kockx Belgium	54	3.4k 1.2×	2.5k 1.3×	1.9k 1.0×	1.4k 0.9×	1.2k 0.9×	176	9.2k
Giuseppe Danilo Norata Italy	57	2.7k 0.9×	3.3k 1.7×	3.0k 1.5×	1.4k 0.9×	1.8k 1.4×	235	10.5k
Hiroyuki Itabe Japan	49	3.1k 1.1×	2.8k 1.4×	2.2k 1.1×	633 0.4×	978 0.8×	166	9.3k
Steven R. Lentz United States	60	2.3k 0.8×	1.2k 0.6×	1.6k 0.8×	530 0.3×	1.5k 1.2×	199	10.6k
Anthony J. Valente United States	55	2.9k 1.0×	3.2k 1.6×	1.5k 0.8×	1.0k 0.7×	1.2k 1.0×	122	8.9k

Countries citing papers authored by Luis Miguel Blanco‐Colio

Since Specialization

Citations

This map shows the geographic impact of Luis Miguel Blanco‐Colio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Miguel Blanco‐Colio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Miguel Blanco‐Colio more than expected).

Fields of papers citing papers by Luis Miguel Blanco‐Colio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Miguel Blanco‐Colio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Miguel Blanco‐Colio. The network helps show where Luis Miguel Blanco‐Colio may publish in the future.

Co-authorship network of co-authors of Luis Miguel Blanco‐Colio

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Miguel Blanco‐Colio. A scholar is included among the top collaborators of Luis Miguel Blanco‐Colio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Miguel Blanco‐Colio. Luis Miguel Blanco‐Colio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blanco‐Colio, Luis Miguel, José Luis Martín‐Ventura, Ignacio Mahíllo, et al.. (2025). High Levels of Galectin-3 and Uric Acid Are Independent Predictors of Renal Impairment in Patients with Stable Coronary Artery Disease. Journal of Clinical Medicine. 14(15). 5264–5264.

Gutiérrez‐Muñoz, Carmen, María José Fernández Gómez, Pablo Mínguez, et al.. (2025). Annexin A8 deficiency delays atherosclerosis progression. Clinical and Translational Medicine. 15(1). e70176–e70176. 1 indexed citations

Tarín, Nieves, Carmen Cristóbal, Ana Huelmos, et al.. (2024). Beyond secondary prevention drugs: Added benefit in survival and events of a healthy lifestyle in patients after an acute coronary syndrome. SHILAP Revista de lepidopterología. 21. 100923–100923. 1 indexed citations

Blanco‐Colio, Luis Miguel, et al.. (2024). In vitro 3D co-culture model of human endothelial and smooth muscle cells to study pathological vascular remodeling. Clínica e Investigación en Arteriosclerosis (English Edition). 36(6). 356–363.

Jover, Eva, Ernesto Martín‐Núñez, Lara Matilla, et al.. (2024). Sex‐dependent expression of galectin‐1, a cardioprotective β‐galactoside‐binding lectin, in human calcific aortic stenosis. The FASEB Journal. 38(3). e23447–e23447. 1 indexed citations

Lopez‐Sanz, Laura, et al.. (2023). The presence of activating IgG Fc receptors in macrophages aggravates the development of experimental abdominal aortic aneurysm. Clínica e Investigación en Arteriosclerosis (English Edition). 35(4). 185–194.

Aceña, Álvaro, Ana María Pello, Juan Martínez‐Milla, et al.. (2021). Parathormone Levels Add Prognostic Ability to N-Terminal Pro-Brain Natriuretic Peptide in Stable Coronary Patients. ESC Heart Failure. 8(4). 2713–2722. 10 indexed citations

Canyelles, Marina, Mireia Tondo, Jes S. Lindholt, et al.. (2020). Macrophage Cholesterol Efflux Downregulation Is Not Associated with Abdominal Aortic Aneurysm (AAA) Progression. Biomolecules. 10(4). 662–662. 2 indexed citations

Martínez-López, Diego, Emilio Camafeita, Lídia Cedó, et al.. (2019). APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm. EBioMedicine. 43. 43–53. 33 indexed citations

10.

Sastre, Cristina, José Manuel Valdivielso, Àngels Betriu, et al.. (2016). Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD. Clinical Journal of the American Society of Nephrology. 11(3). 413–422. 18 indexed citations

11.

Burillo, Elena, Inmaculada Jorge, Diego Martínez-López, et al.. (2016). Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm. Scientific Reports. 6(1). 38477–38477. 27 indexed citations

12.

Tuñón, José, Luis Miguel Blanco‐Colio, Carmen Cristóbal, et al.. (2013). Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery Disease. The American Journal of Cardiology. 113(3). 434–440. 65 indexed citations

13.

Yılmaz, Mahmut İlker, Alper Sönmez, Alberto Ortíz, et al.. (2011). Soluble TWEAK and PTX3 in Nondialysis CKD Patients. Clinical Journal of the American Society of Nephrology. 6(4). 785–792. 84 indexed citations

14.

Martínez-Pinna, Roxana, Priscila Ramos‐Mozo, Julio Madrigal‐Matute, et al.. (2011). Identification of Peroxiredoxin-1 as a Novel Biomarker of Abdominal Aortic Aneurysm. Arteriosclerosis Thrombosis and Vascular Biology. 31(4). 935–943. 67 indexed citations

15.

Sanz, Ana B., María Dolores Sánchez-Niño, María C. Izquierdo, et al.. (2010). TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21. PLoS ONE. 5(1). e8955–e8955. 85 indexed citations

16.

Blanco‐Colio, Luis Miguel, José Luis Martín‐Ventura, Eduardo de Teresa, et al.. (2007). Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: A substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. American Heart Journal. 153(5). 881–888. 73 indexed citations

17.

Martín‐Ventura, José Luis, Anne Leclercq, Luis Miguel Blanco‐Colio, et al.. (2006). Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. Atherosclerosis. 194(2). 334–341. 48 indexed citations

18.

Blanco‐Colio, Luis Miguel. (2005). Inflammatory biomarkers and statins. Drugs of today. 41(3). 171–171. 3 indexed citations

19.

Blanco‐Colio, Luis Miguel, José Luis Martín‐Ventura, J. M. Sol, et al.. (2004). Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis. Journal of the American College of Cardiology. 43(7). 1188–1194. 30 indexed citations

20.

Blanco‐Colio, Luis Miguel, Begoña Muñoz‐García, José Luis Martín‐Ventura, et al.. (2003). 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Decrease Fas Ligand Expression and Cytotoxicity in Activated Human T Lymphocytes. Circulation. 108(12). 1506–1513. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact